CPHI Milan 2
CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Product Liability: Navigating a Restrictive Market

Insurers are facing a growing number of product liability claims in what is becoming an increasingly litigious environment in the UK and Europe. Stricter regulation, a high-pressured economic environment and complex supply chains are only some of the factors driving this trend. As a result, it is often difficult to maintain access to broad and affordable product liability cover. Andrew Catton of Miller Insurance Services LLP explains why product liability insurance is becoming more restrictive for many pharmaceutical, biotech and medical equipment companies, and what organisations can do to maintain affordable cover.

https://international-pharma.com/wp-content/uploads/2012/09/Pages-from-IPI-Volume4Issue3-15.pdf

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026